Boardroom Alpha
Meeting calendar
IONQ · Annual meeting · Tuesday, June 16, 2026

Ionq Inc

2 nominees · 3 ballot items.

Elect two Class II directors; ratify Ernst & Young LLP as the independent registered public accounting firm for 2026; and approve, on an advisory basis, the compensation of the company’s named executive officers for 2025.

Market cap
$13.0B
1Y TSR
+14.0%
Board grade
B
Record date
Apr 17, 2026
Filing
DEF 14A
Meeting concluded · Jun 16, 2026

Follow how the vote landed and what changed on Ionq Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Class II Directors

    ManagementBoard: FOR

    Elect two Class II director nominees (Kathryn K. Chou and William F. Scannell) to hold office until the 2029 Annual Meeting and until their successors are elected and qualified.

  2. 2

    Ratification of Appointment of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026.

  3. 3

    Advisory Vote to Approve the Compensation of Our Named Executive Officers for 2025 (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the named executive officers for 2025 as disclosed in the proxy statement (CD&A, compensation tables and narrative).

    More detail

    This advisory proposal asks stockholders to endorse, on a non-binding basis, the total compensation paid to the Company’s named executive officers for 2025 as disclosed in the proxy (including the CD&A, tables and narrative). Management seeks the vote to demonstrate stockholder support for its pay philosophy and the specific compensation decisions made during a transformative year that included a new CEO appointment, multiple senior hires, significant ‘‘make-whole’’ and sign‑on equity grants, and adjustments to PSU performance targets. The Board frames these awards as necessary to attract and retain highly specialized leadership in the competitive quantum/AI talent market and to align incentives with long‑term value creation, emphasizing heavy weighting toward performance-based equity. The context includes strong operational performance in 2025 (notably ~202% revenue growth to $130M), major acquisitions and strategic shifts to a full‑stack quantum platform that the Board says justify the compensation structure. The Company also faced prior stockholder concern on pay (a ~64% Say‑on‑Pay support in 2025) and undertook outreach, and the Compensation Committee made program adjustments and disclosure enhancements in response (for example, reaffirming an end to one‑time discretionary cash awards for current management and shifting PSU weightings toward revenue). Management’s counter-argument to potential criticism is that the grants and PSU adjustments are calibrated to rigorous, updated budgets and are designed to be both retention- and performance‑oriented, with maximum PSU payout reduced relative to prior programs and vesting tied to multi‑year goals. The Board notes the vote is advisory and will be considered in future compensation decisions; it recommends FOR the proposal on the basis that the program aligns executive incentives with strategic objectives and long‑term stockholder value.

Director elections

Nominees on the ballot2

Independent
Tenure on this board
0.3 yrs
Also a director at
Snowflake Inc (SNOW)
Ownership

Top institutional holders10

Latest 13F quarter
1MORGAN STANLEY4.7%17,568,356$506M
2VANGUARD PORTFOLIO MANAGEMENT LLC4.1%15,389,580$444M
3VANGUARD CAPITAL MANAGEMENT LLC4.0%15,064,048$434M
4BlackRock, Inc.3.5%13,146,752$379M
5BlackRock, Inc.2.9%10,747,105$310M
6Defiance ETFs, LLC2.6%9,702,302$280M
7STATE STREET CORP2.5%9,270,862$267M
8GEODE CAPITAL MANAGEMENT, LLC1.9%7,209,269$207M
9UBS Group AG1.5%5,550,586$160M
10Marex Group plc0.9%3,502,958$101M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Ionq Inc 2026 annual meeting?
Ionq Inc (IONQ) holds its 2026 annual shareholder meeting on Tuesday, June 16, 2026.
What is the record date for the Ionq Inc 2026 meeting?
The record date for the Ionq Inc 2026 meeting is Friday, April 17, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Ionq Inc's 2026 meeting?
The board is presenting 2 director nominees at the Ionq Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Ionq Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Ionq Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer